Anti-SOX9 antibody [EPR14335-78] (Ab185966)

Anti-SOX9 antibody [EPR14335-78] (ab185966) was developed by Abcam using patented rabbit monoclonal antibody technology and is validated for use in Flow Cyt (Intra), ICC/IF, IHC-P and WB. Anti-SOX9 antibody [EPR14335-78] (ab185966) was first used in a scientific publication in 2015 and has been cited over 245 times in peer reviewed journals. It's performance in IHC and Western Blot in mouse and human samples is trusted by the scientific community. Abcam's high quality manufacturing and validation processes ensure Anti-SOX9 antibody [EPR14335-78] (ab185966) has high sensitivity and specificity alongside high lot-to-lot consistency and reproducibility. Anti-SOX9 antibody [EPR14335-78] (ab185966) has 26 independent reviews from customers. Anti-SOX9 antibody [EPR14335-78] (ab185966) specifically detects SOX9 (UniProt ID: P48436; Molecular weight: 57kDa) and is sold in 100 µL and 1 mL selling sizes. Conjugation-ready, carrier free format available for antibody clone EPR14335-78 - ab225541. Antibody clone EPR14335-78 is also available pre-conjugated to a variety of labels for your convenience - Alexa Fluor ® 647, Alexa Fluor ® 488, PE ( ab207677, ab208427, ab224019 ). Top cited monoclonal for this target with >350 citations. Highly specific SOX9 antibody to study several important processes such as chondrogenesis and stem cell differentiation. SOX9 plays a multifaceted role in cancer development and progression. It functions as an oncogene in various cancers, including colorectal, ovarian and breast cancers. SOX9 promotes tumor initiation, proliferation, migration, invasion and chemoresistance by regulating key signalling pathways and gene expression. Additionally, SOX9 is involved in maintaining cancer stem cell properties, contributing to tumor growth and metastasis. Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents. What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies.